Darren Ji is the Chairman and CEO of Elpiscience Biopharmaceuticals. He also serves as a board director at Legend Biotech (NASDAQ: LEGN). Previously, Darren was a Venture Partner at Lilly Asia Ventures (LAV), where he co-founded Elpiscience in 2017.

Before that, Darren served as Global Head and Vice President of Roche Business Development for Asia and Emerging Markets. In this role, he led strategy and deal execution across more than 100 countries, championing and closing numerous key transactions. He managed a global team and built a strong business network in major markets, including China, Japan, Korea, Australia/New Zealand, Russia, and Brazil.

A serial entrepreneur, Darren has a distinguished career spanning drug R&D and business development. He held leadership roles at Procter & Gamble and co-founded PharmaLegacy Laboratories, where he served as CEO. A highly respected figure in global life sciences, he is a sought-after speaker at industry forums and an active community builder. He was one of the longest board members of BayHelix Group, a community of life science business leaders of Chinese heritage. He currently serves on the Advisory Committee to BioCEO and Investor Conference.

Darren holds an M.D. from China Medical University, a Ph.D. from the University of Sheffield, and an MBA from the University of Chicago.